Free Trial

Benitec Biopharma (BNTC) Short Interest Ratio & Short Volume

Benitec Biopharma logo
$10.30 -0.76 (-6.87%)
As of 01/17/2025 04:00 PM Eastern

Benitec Biopharma Short Interest Data

Benitec Biopharma (BNTC) has a short interest of 62,300 shares. This marks a 65.69% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 79,139 shares to cover all short positions.

Current Short Interest
62,300 shares
Previous Short Interest
37,600 shares
Change Vs. Previous Month
+65.69%
Dollar Volume Sold Short
$786,849.00
Short Interest Ratio
1.1 Days to Cover
Last Record Date
December 31, 2024
Outstanding Shares
23,220,000 shares
Percentage of Shares Shorted
0.27%
Today's Trading Volume
30,696 shares
Average Trading Volume
79,139 shares
Today's Volume Vs. Average
39%
Short Selling Benitec Biopharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Benitec Biopharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BNTC Short Interest Over Time

BNTC Days to Cover Over Time

BNTC Percentage of Float Shorted Over Time

Benitec Biopharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/202462,300 shares $786,849.00 +65.7%N/A1.1 $12.63
12/15/202437,600 shares $442,552.00 +6.2%N/A0.7 $11.77
11/30/202435,400 shares $357,186.00 +7.0%N/A0.9 $10.09
11/15/202433,100 shares $353,508.00 -41.8%N/A1 $10.68
10/31/202456,900 shares $598,019.00 +49.0%N/A2 $10.51
10/15/202438,200 shares $374,742.00 -28.1%N/A1.3 $9.81
9/30/202453,100 shares $487,989.00 -10.2%N/A2 $9.19
9/15/202459,100 shares $481,665.00 -4.7%N/A2.6 $8.15
8/31/202462,000 shares $573,190.00 -6.8%N/A2.1 $9.25
8/15/202466,500 shares $571,900.00 -2.2%N/A2 $8.60
7/31/202468,000 shares $599,760.00 -18.2%N/A1.8 $8.82
7/15/202483,100 shares $847,620.00 -10.0%3.7%2 $10.20
6/30/202492,300 shares $645,177.00 +871.6%4.1%0.9 $6.99
6/15/20249,500 shares $69,445.00 -25.8%0.4%0.1 $7.31
5/31/202412,800 shares $97,920.00 -77.2%0.6%0.1 $7.65
5/15/202456,100 shares $496,485.00 -43.1%2.5%0.6 $8.85
4/30/202498,500 shares $832,325.00 +707.4%6.3%1.2 $8.45
4/15/202412,200 shares $59,902.00 +10.9%0.5%0.2 $4.91
3/31/202411,000 shares $57,750.00 +115.7%0.5%0.7 $5.25
3/15/20245,100 shares $26,010.00 -68.3%0.2%0.4 $5.10
2/29/202416,100 shares $78,085.00 +151.6%0.7%1.1 $4.85
2/15/20246,400 shares $18,432.00 -18.0%0.3%0.5 $2.88
1/31/20247,800 shares $21,918.00 +25.8%0.3%0.9 $2.81
1/15/20246,200 shares $18,166.00 -18.4%0.3%0.7 $2.93
12/31/20237,600 shares $24,548.00 -39.7%0.3%0.7 $3.23
12/15/202312,600 shares $42,462.00 +5.9%0.6%1.1 $3.37
11/30/202311,900 shares $37,842.00 -64.4%0.5%0.8 $3.18
11/15/202333,400 shares $125,918.00 -28.2%1.5%1.6 $3.77
10/31/202346,500 shares $167,865.00 -20.7%3.1%0.6 $3.61
10/15/202358,600 shares $199,826.00 -13.7%3.9%0.1 $3.41
9/30/202367,900 shares $205,173.43 -24.7%4.6%0.1 $3.02
9/15/202390,200 shares $285,032.00 -33.8%6.1%0.1 $3.16
8/31/2023136,300 shares $402,085.00 -51.1%9.2%0.2 $2.95
8/15/2023278,500 shares $749,165.00 +52.2%N/A0.4 $2.69
7/31/2023183,000 shares $563,640.00 -81.2%N/A0.3 $3.08
7/15/2023974,300 shares $223,991.57 -57.3%N/A0.3 $0.23
6/30/20232,280,000 shares $543,780.00 +1,061.5%N/A0.7 $0.24
6/15/2023196,300 shares $46,110.87 -22.8%N/A0.1 $0.23
5/31/2023254,300 shares $61,311.73 -19.9%N/A0.9 $0.24
5/15/2023317,400 shares $67,856.95 -5.8%N/A1.1 $0.21
Bitcoin to $200K? (Ad)

Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. Today, he says there's a much smaller crypto – trading for less than $1 – that's likely to deliver way bigger gains than Bitcoin.

This is the #1 crypto you should buy in 2025.
4/30/2023337,000 shares $67,770.70 +77.9%N/A1 $0.20
4/15/2023189,400 shares $40,436.71 +73.4%N/A0.6 $0.21
3/31/2023109,200 shares $22,921.08 -45.0%N/A0.4 $0.21
3/15/2023198,700 shares $46,694.50 -52.5%N/A0.6 $0.24
2/28/2023418,700 shares $125,610.00 +101.1%N/A0.9 $0.30
2/15/2023208,200 shares $47,760.87 -3.6%N/A0.5 $0.23
1/31/2023215,900 shares $49,657.00 -1.7%N/A0.5 $0.23
1/15/2023219,600 shares $50,925.24 +109.9%N/A0.4 $0.23
12/30/2022104,600 shares $17,782.00 +245.2%N/A0.2 $0.17
12/15/202230,300 shares $4,545.00 -85.3%N/A0.1 $0.15
11/30/2022206,400 shares $42,312.00 +24.9%N/A0.3 $0.21
11/15/2022165,200 shares $28,596.12 -50.6%N/A0.3 $0.17
10/31/2022334,500 shares $58,637.85 +310.4%4.5%0.6 $0.18
10/15/202281,500 shares $19,486.65 -35.1%1.1%0.2 $0.24
9/30/2022125,600 shares $46,685.52 +187.4%2.1%0.4 $0.37
9/15/202243,700 shares $18,747.30 -87.7%0.6%0 $0.43
8/31/2022354,900 shares $262,519.53 +26.8%5.0%0.2 $0.74
8/15/2022279,900 shares $236,529.50 +353.7%4.0%0.1 $0.85
7/31/202261,700 shares $55,462.13 -40.1%0.9%0 $0.90
7/15/2022103,000 shares $110,210.00 -92.5%1.5%0 $1.07
6/30/20221,370,000 shares $1.59 million +13,738.4%19.5%0.6 $1.16
6/15/20229,900 shares $8,613.99 +23.8%0.1%0 $0.87
5/31/20228,000 shares $8,400.00 +281.0%0.1%0.3 $1.05
5/15/20222,100 shares $2,486.61 -56.3%0.0%0.1 $1.18
4/30/20224,800 shares $7,200.00 +166.7%0.1%0.2 $1.50
4/15/20221,800 shares $3,597.30 -67.9%0.0%0.1 $2.00
3/31/20225,600 shares $13,076.00 +75.0%0.1%0.2 $2.34
3/15/20223,200 shares $6,624.00 -70.1%0.1%0.1 $2.07
2/28/202210,700 shares $24,824.00 -17.1%0.2%0.3 $2.32
2/15/202212,900 shares $34,959.00 +84.3%0.2%0.4 $2.71
1/31/20227,000 shares $17,150.00 -77.4%0.1%0.2 $2.45
1/15/202231,000 shares $79,360.00 +121.4%0.4%0.8 $2.56
12/31/202114,000 shares $36,680.00 +17.7%0.2%0.4 $2.62
12/15/202111,900 shares $34,391.00 -13.1%0.2%0.3 $2.89
11/30/202113,700 shares $41,922.00 -9.3%0.2%0.1 $3.06
11/15/202115,100 shares $51,944.00 -29.8%0.2%0.1 $3.44
10/29/202121,500 shares $78,690.00 -21.3%0.3%0.2 $3.66
10/15/202127,300 shares $98,007.00 -1.1%0.4%0.2 $3.59
9/30/202127,600 shares $98,532.00 -78.0%0.4%0.2 $3.57
9/15/2021125,700 shares $487,716.00 -19.5%1.9%0.7 $3.88
8/31/2021156,200 shares $618,552.00 -25.1%3.9%1.5 $3.96
8/13/2021208,400 shares $827,348.00 +7.1%5.2%2 $3.97
7/30/2021194,600 shares $681,100.00 -2.5%4.9%0.7 $3.50
7/15/2021199,500 shares $758,100.00 -14.2%5.0%0.6 $3.80
6/30/2021232,400 shares $987,700.00 -18.1%5.8%0.6 $4.25
6/15/2021283,800 shares $1.25 million -19.8%7.1%0.4 $4.40
5/28/2021354,000 shares $1.67 million -6.4%8.9%0.1 $4.71
5/14/2021378,000 shares $1.77 million -0.2%9.5%0.1 $4.69
4/30/2021378,700 shares $1.61 million +35.0%12.0%0.1 $4.25
4/15/2021280,600 shares $1.46 million +21.0%7.8%0.1 $5.21
Warren Buffett Bets $40 Billion—You Can Get in for $20 (Ad)

I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in this sector.

Click Here to Get All the Details >>>
3/31/2021232,000 shares $997,600.00 +422.5%6.0%0.1 $4.30
3/15/202144,400 shares $146,076.00 +45.6%1.0%0 $3.29
2/26/202130,500 shares $106,902.50 -13.4%0.7%0.1 $3.51
2/12/202135,200 shares $174,592.00 +9.7%N/A0.1 $4.96
1/29/202132,100 shares $130,005.00 +79.3%2.3%0.1 $4.05
1/15/202117,900 shares $65,335.00 -57.8%1.3%0 $3.65
12/31/202042,400 shares $134,832.00 +480.8%3.2%0.1 $3.18
12/15/20207,300 shares $19,856.00 -84.9%0.5%0 $2.72
11/30/202048,400 shares $142,296.00 +44.9%3.6%0.1 $2.94
11/15/202033,400 shares $96,038.36 +475.9%2.5%0.1 $2.88
10/30/20205,800 shares $15,950.00 -68.0%0.4%0.1 $2.75
10/15/202018,100 shares $52,490.00 -54.6%1.4%0.2 $2.90
9/30/202039,900 shares $250,572.00 +100.5%3.6%0.6 $6.28
9/15/202019,900 shares $118,846.78 +19.9%1.3%1.5 $5.97
8/31/202016,600 shares $115,536.00 +1,409.1%1.0%0.6 $6.96
8/14/20201,100 shares $9,042.00 -79.6%0.1%0 $8.22
7/31/20205,400 shares $38,556.00 +3.9%0.3%0.2 $7.14
7/15/20205,200 shares $36,244.00 +44.4%0.3%0.2 $6.97
6/30/20203,600 shares $28,728.00 +414.3%0.2%0.1 $7.98
6/15/2020700 shares $5,656.00 -82.9%0.0%0 $8.08
5/29/20204,100 shares $28,987.00 -65.6%0.3%0.1 $7.07
5/15/202011,900 shares $99,484.00 +271.9%0.8%0.2 $8.36
4/30/20203,200 shares $29,120.00 +10.3%0.0%0 $9.10
4/15/20202,900 shares $15,704.37 -71.3%N/A0 $5.42
3/31/202010,100 shares $110,393.00 +405.0%N/A0.1 $10.93
3/13/20202,000 shares $8,800.00 -13.0%N/A0.1 $4.40
2/28/20202,300 shares $7,291.00 -32.4%N/A0 $3.17
2/14/20203,400 shares $14,144.00 +240.0%N/A0 $4.16
1/31/20201,000 shares $4,490.00 -16.7%N/A0 $4.49

BNTC Short Interest - Frequently Asked Questions

What is Benitec Biopharma's current short interest?

Short interest is the volume of Benitec Biopharma shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 62,300 shares of BNTC short. Learn More on Benitec Biopharma's current short interest.

What is a good short interest ratio for Benitec Biopharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNTC shares currently have a short interest ratio of 1.0. Learn More on Benitec Biopharma's short interest ratio.

Is Benitec Biopharma's short interest increasing or decreasing?

Benitec Biopharma saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 62,300 shares, an increase of 65.7% from the previous total of 37,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Benitec Biopharma's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Benitec Biopharma: Adaptive Biotechnologies Co. (6.23%), Gyre Therapeutics, Inc. (4.37%), Poseida Therapeutics, Inc. (3.67%), Oculis Holding AG (0.16%), Nuvation Bio Inc. (9.14%), Anavex Life Sciences Corp. (25.70%), AbCellera Biologics Inc. (7.47%), CureVac (4.08%), ArriVent BioPharma, Inc. (19.54%), Cogent Biosciences, Inc. (7.22%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Benitec Biopharma stock?

Short selling BNTC is an investing strategy that aims to generate trading profit from Benitec Biopharma as its price is falling. BNTC shares are trading down $0.76 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Benitec Biopharma?

A short squeeze for Benitec Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BNTC, which in turn drives the price of the stock up even further.

How often is Benitec Biopharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNTC, twice per month. The most recent reporting period available is December, 31 2024.




This page (NASDAQ:BNTC) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners